Clinical Trials Logo

Angioplasty, Balloon clinical trials

View clinical trials related to Angioplasty, Balloon.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02599389 Recruiting - Clinical trials for Angioplasty, Balloon

Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis

INTACT
Start date: December 2015
Phase: Phase 3
Study type: Interventional

The aim of this multicenter triple-arm randomized study is to compare two innovative techniques with the gold standard currently used and providing unsatisfactory results for the In-Stent Restenosis (ISR) treatment in femoro-popliteal arteries. This protocol compares the use of drug-coated balloons (paclitaxel - antimitotic) used alone or in association with the Excimer Laser to recalibrate the vessel lumen into the stent by destroying the whole fibrous material to the standard angioplasty using plain balloons. INTACT study main objective is to assess cost-effectiveness ratio of the treatment of femoropopliteal artery in-stent restenosis by comparing these two innovative strategies and the standard one in terms of cost per Qaly (Quality adjusted life-years) gained at 18 months from a collective perspective.

NCT ID: NCT02038660 Recruiting - Clinical trials for Coronary Artery Disease

Drug-Eluting Balloon Registry in Routine Clinical Practice

IRIS DEB
Start date: January 2014
Phase:
Study type: Observational

The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.

NCT ID: NCT00327041 Recruiting - Coronary Stenosis Clinical Trials

Monitoring Response to Antiplatelet Therapy

Start date: January 2006
Phase: Phase 4
Study type: Observational

Antiplatelet therapy plays a key role in the prevention of complications related to coronary angioplasty and stenting (PCI) including procedure related myocardial damage. Aspirin and clopidogrel are now universally prescribed in patients undergoing these procedures. However, loading and maintenance doses have not been established and variation in individual response is emerging. New tests to assess the effects of these drugs are being developed but have yet to be incorporated into routine clinical practice. We will assess the effects of aspirin and clopidogrel in a consecutive series of patients undergoing angioplasty using new assays which can be carried out at the bedside. We will compare the results with alternative laboratory based tests and look for an association between the results, peri-procedural myocardial necrosis and subsequent cardiovascular events.